Sector Update: Health Care
MT Newswires · 1d ago
Agile Therapeutics prices $24M upsized stock offering
Agile Therapeutics (NASDAQ:AGRX) <a href="https://seekingalpha....
Seekingalpha · 1d ago
BRIEF-Agile Therapeutics Announces Pricing Of $24 Mln Upsized Public Offering
BRIEF-Agile Therapeutics Announces Pricing Of $24 Mln Upsized Public Offering
Reuters · 1d ago
Agile Therapeutics Announces Pricing of $24M Upsized Public Offering
Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its upsized public offering of an aggregate of
Benzinga · 1d ago
Update: Agile Therapeutics Prices $24 Million Upsized Securities Offering; Shares Decline
MT Newswires · 2d ago
Agile Therapeutics Prices $24 Million Upsized Securities Offering
MT Newswires · 2d ago
ArcelorMittal, Universal Health Services, RH among premarket losers' pack
Renalytix (RNLX) -28% on <a href="
Seekingalpha · 2d ago
U.S. Stocks Turn Negative; 2U Shares Spike Higher
U.S. stocks pared gains midway through trading, with all the three major indices turning lower on Wednesday.
Benzinga · 3d ago
Healthcare Breakthroughs: KZR, NMLSF, AGRX, LMLLF Report Latest Advances in Novel Therapeutics for Inflammatory Diseases, Oncology, and Autism
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Kezar Life Sciences (NASDAQ: KZR), Nova Mentis Life Sciences (OTC: NML...
GlobeNewswire · 4d ago
NS, MNTS and AGRX among pre market gainers
Kezar Life Sciences (KZR) +93% after mid-stage data for lupus nephritis candidate. Agile Therapeutics (AGRX) +46%. Evofem Biosciences (EVFM) +33% collaboration for birth control method. InflaRx (IFRX) +17% on vilobelimab getting FDA orphan drug
Seekingalpha · 4d ago
NeuroSense, Axsome top healthcare gainers; GeoVax, SIGA lead losers' pack
Gainers: NeuroSense Therapeutics (NRSN) +83%. Axsome Therapeutics (AXSM) +37%. Agile Therapeutics (AGRX) +31%. GreenLight Biosciences (GRNA) +26%. Femasys (FEMY) +11%. Losers: GeoVax Labs (GOVX) -14%. SIGA Technologies (SIGA) -14%. Eargo (EAR) -12%. BioAtl...
Seekingalpha · 5d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 5d ago
CLVS, TCOM and GTE among pre market gainers
Axsome Therapeutics (AXSM) +50%as FDA issues proposed labeling for depression drug. Agile Therapeutics (AGRX) +42%. Nutex Health (NUTX) +14%announces that it has been selected to join both the RUSSELL 2000® AND
Seekingalpha · 5d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Investor Place · 5d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Investor Place · 06/02 11:24
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
Benzinga · 06/02 10:55
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 05/31 21:37
BRIEF-Agile Therapeutics CFO Notified Co That He Will Voluntarily Resign To Retire · 05/23 13:17
Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference
PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari, Chairman and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference taki...
GlobeNewswire · 05/17 12:01
XERS, AGRX and LHDX among mid-day movers
Gainers: Data Storage Corporation (DTST) +40%. Indonesia Energy Corporation (INDO) +30%. Harpoon Therapeutics (HARP) +28%. Pulse Biosciences (PLSE) +24%. Praxis Precision Medicines (PRAX) +24%. Xeris Biopharma Holdings (XERS) +24%. Griffon
Seekingalpha · 05/16 16:31
Webull provides a variety of real-time AGRX stock news. You can receive the latest news about Agile Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About AGRX
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The Company commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.